2026-04-10 · Research summary
Best healing peptides for research in 2026
BPC-157 remains the most-studied research peptide for soft-tissue repair; GHK-Cu leads dermal regeneration; KPV and larazotide dominate gut-barrier research; LL-37 sits at the antimicrobial-host-defence intersection.
Tier 1 — deepest evidence base
BPC-157 (tendon, ligament, gut), GHK-Cu (skin), and thymosin beta-4 (cardiac, corneal). These three peptides have the largest independent pre-clinical literatures and the clearest mechanistic stories.
Tier 2 — strong niche evidence
TB-500 (with appropriate caveats about fragment identity), KPV (gut and skin inflammation), LL-37 (antimicrobial wound research), larazotide (intestinal tight junctions).
Tier 3 — emerging or specialised
AC-SDKP (anti-fibrotic), epitalon (cellular ageing models), AOD-9604 (cartilage research), pentosan polysulfate (osteoarthritis and bladder research).
What 2026 research should clarify
The field would benefit most from independent multi-centre replication of headline BPC-157 tendon findings, properly characterised TB-500 versus full-length Tβ4 comparisons, and long-term safety data for compounds entering grey-market human use.
Where to source research peptides for laboratory research
The following UK-based suppliers stock research-grade, lyophilised peptides for in-vitro and pre-clinical work. Purity and provenance vary; always request a Certificate of Analysis (CoA) and confirm cold-chain storage on arrival. None of the products linked below are approved for human use.
- PeptideAuthority.co.uk
UK-based research peptide supplier with batch certificates of analysis and >99% purity testing.
- PeptideBarn.co.uk
Wide catalogue of research-grade lyophilised peptides shipped from the UK, including bulk vials.